肯尼亚和津巴布韦顺性别妇女对阴道避孕环、避孕药和注射剂的可接受性比较:一项混合方法研究方案。

Gates Open Research Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI:10.12688/gatesopenres.16315.1
Chelsea B Polis, Francis O Obare, Irene V Bruce, Cynthia Banda, Lisa B Haddad, Antwanette Heyns, Petros Isaakidis, Mercy Kamupira, Terrance Kufakunesu, Zachary A Kwena, Farai Machinga, Regina F Magore, Aleck Mapangire, Mercy Marimirofa, Matheus Mathipa, Sanyukta Mathur, Mary Mudavanhu, Tatenda P Mujuru, Prisca Mutero, Betty Njoroge, Collen Nyatsambo, Sarah Okumu, Leah Omondi, Tevyne Omondi, Marlena G Plagianos, Greshon Rota, Samuel Sithole, Bruce Variano, J Brady Burnett-Zieman, Petina Musara, George Odwe, Gerald Hangaika, Serah Gitome, Elizabeth A Bukusi, Kuziwa Kuwenyi
{"title":"肯尼亚和津巴布韦顺性别妇女对阴道避孕环、避孕药和注射剂的可接受性比较:一项混合方法研究方案。","authors":"Chelsea B Polis, Francis O Obare, Irene V Bruce, Cynthia Banda, Lisa B Haddad, Antwanette Heyns, Petros Isaakidis, Mercy Kamupira, Terrance Kufakunesu, Zachary A Kwena, Farai Machinga, Regina F Magore, Aleck Mapangire, Mercy Marimirofa, Matheus Mathipa, Sanyukta Mathur, Mary Mudavanhu, Tatenda P Mujuru, Prisca Mutero, Betty Njoroge, Collen Nyatsambo, Sarah Okumu, Leah Omondi, Tevyne Omondi, Marlena G Plagianos, Greshon Rota, Samuel Sithole, Bruce Variano, J Brady Burnett-Zieman, Petina Musara, George Odwe, Gerald Hangaika, Serah Gitome, Elizabeth A Bukusi, Kuziwa Kuwenyi","doi":"10.12688/gatesopenres.16315.1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Expanding contraceptive options could better meet users' diverse needs and preferences. Annovera <sup>®</sup> is a contraceptive vaginal ring that provides a year of pregnancy prevention while remaining under user control and allowing for regular menstrual cycles. This method may also help to reduce burdens on some health care and supply chain systems. However, knowledge gaps exist regarding initial and ongoing acceptability of contraceptive vaginal rings in African settings.</p><p><strong>Methods: </strong>We will undertake an open-label, non-randomized, two-arm, parallel clinical acceptability study with an embedded qualitative component, based in clinics providing contraceptive services in Kenya and Zimbabwe. Women aged 18-45 interested in newly initiating or switching contraception will choose from among all available contraceptive options, including Annovera. We aim to enroll 200 participants selecting Annovera and 200 participants selecting either contraceptive injectables or pills. We will compare method uptake, continuation, and satisfaction over one year. Participants will complete questionnaires administered by study staff during two in-person visits (a screening/enrollment visit, and an end of study visit after 52 weeks of method use or at discontinuation) and four phone appointments (at 4, 12, 24, and 36 weeks of use). We will evaluate used rings for discoloration and residual drug levels. The qualitative component involve in-depth interviews with women in the clinical study, their sexual partners, and their service providers, to further examine drivers of and barriers to interest in and use of contraceptive vaginal rings.</p><p><strong>Discussion: </strong>This study will explore acceptability of contraceptive vaginal rings in 'real-world' contraceptive service settings in two African countries. Findings will be based on actual ring use and contextualized via comparison to two other commonly available methods. As vaginal rings are being considered for multiple reproductive health indications, this work can fill key knowledge gaps and empower decision-makers with information needed to inform future investments in reproductive health.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"9 ","pages":"5"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876155/pdf/","citationCount":"0","resultStr":"{\"title\":\"A comparison of acceptability of contraceptive vaginal rings, pills, and injectables among cisgender women in Kenya and Zimbabwe: protocol for a mixed-methods study.\",\"authors\":\"Chelsea B Polis, Francis O Obare, Irene V Bruce, Cynthia Banda, Lisa B Haddad, Antwanette Heyns, Petros Isaakidis, Mercy Kamupira, Terrance Kufakunesu, Zachary A Kwena, Farai Machinga, Regina F Magore, Aleck Mapangire, Mercy Marimirofa, Matheus Mathipa, Sanyukta Mathur, Mary Mudavanhu, Tatenda P Mujuru, Prisca Mutero, Betty Njoroge, Collen Nyatsambo, Sarah Okumu, Leah Omondi, Tevyne Omondi, Marlena G Plagianos, Greshon Rota, Samuel Sithole, Bruce Variano, J Brady Burnett-Zieman, Petina Musara, George Odwe, Gerald Hangaika, Serah Gitome, Elizabeth A Bukusi, Kuziwa Kuwenyi\",\"doi\":\"10.12688/gatesopenres.16315.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Expanding contraceptive options could better meet users' diverse needs and preferences. Annovera <sup>®</sup> is a contraceptive vaginal ring that provides a year of pregnancy prevention while remaining under user control and allowing for regular menstrual cycles. This method may also help to reduce burdens on some health care and supply chain systems. However, knowledge gaps exist regarding initial and ongoing acceptability of contraceptive vaginal rings in African settings.</p><p><strong>Methods: </strong>We will undertake an open-label, non-randomized, two-arm, parallel clinical acceptability study with an embedded qualitative component, based in clinics providing contraceptive services in Kenya and Zimbabwe. Women aged 18-45 interested in newly initiating or switching contraception will choose from among all available contraceptive options, including Annovera. We aim to enroll 200 participants selecting Annovera and 200 participants selecting either contraceptive injectables or pills. We will compare method uptake, continuation, and satisfaction over one year. Participants will complete questionnaires administered by study staff during two in-person visits (a screening/enrollment visit, and an end of study visit after 52 weeks of method use or at discontinuation) and four phone appointments (at 4, 12, 24, and 36 weeks of use). We will evaluate used rings for discoloration and residual drug levels. The qualitative component involve in-depth interviews with women in the clinical study, their sexual partners, and their service providers, to further examine drivers of and barriers to interest in and use of contraceptive vaginal rings.</p><p><strong>Discussion: </strong>This study will explore acceptability of contraceptive vaginal rings in 'real-world' contraceptive service settings in two African countries. Findings will be based on actual ring use and contextualized via comparison to two other commonly available methods. As vaginal rings are being considered for multiple reproductive health indications, this work can fill key knowledge gaps and empower decision-makers with information needed to inform future investments in reproductive health.</p>\",\"PeriodicalId\":12593,\"journal\":{\"name\":\"Gates Open Research\",\"volume\":\"9 \",\"pages\":\"5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876155/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gates Open Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12688/gatesopenres.16315.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gates Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/gatesopenres.16315.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:扩大避孕选择可以更好地满足用户多样化的需求和偏好。Annovera®是一种避孕阴道环,提供一年的怀孕预防,同时保持在用户控制下,并允许有规律的月经周期。这种方法还可能有助于减轻某些卫生保健和供应链系统的负担。然而,关于非洲环境中避孕阴道环的初始和持续可接受性存在知识差距。方法:我们将在肯尼亚和津巴布韦提供避孕服务的诊所开展一项开放标签、非随机、双组、平行临床可接受性研究,并嵌入定性成分。年龄在18-45岁之间的女性对新开始或转换避孕方法感兴趣,将从所有可用的避孕方法中进行选择,包括Annovera。我们的目标是招募200名参与者选择安诺维拉和200名参与者选择避孕注射剂或药丸。我们将比较一年内的方法吸收、延续和满意度。参与者将在两次亲自访问(筛选/登记访问,以及在方法使用52周后或停止使用后的研究结束访问)和四次电话预约(使用第4、12、24和36周)期间完成由研究人员管理的问卷。我们将评估使用过的环的变色和残留药物水平。定性部分涉及对临床研究中的妇女、她们的性伴侣和她们的服务提供者进行深入访谈,以进一步审查对阴道避孕环感兴趣和使用的驱动因素和障碍。讨论:本研究将探讨两个非洲国家在“现实世界”的避孕服务环境中避孕阴道环的可接受性。研究结果将基于戒指的实际使用,并通过与其他两种常用方法的比较来确定。由于目前正在考虑将阴道环用于多种生殖健康适应症,这项工作可以填补关键的知识空白,并为决策者提供必要的信息,为未来的生殖健康投资提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A comparison of acceptability of contraceptive vaginal rings, pills, and injectables among cisgender women in Kenya and Zimbabwe: protocol for a mixed-methods study.

Background: Expanding contraceptive options could better meet users' diverse needs and preferences. Annovera ® is a contraceptive vaginal ring that provides a year of pregnancy prevention while remaining under user control and allowing for regular menstrual cycles. This method may also help to reduce burdens on some health care and supply chain systems. However, knowledge gaps exist regarding initial and ongoing acceptability of contraceptive vaginal rings in African settings.

Methods: We will undertake an open-label, non-randomized, two-arm, parallel clinical acceptability study with an embedded qualitative component, based in clinics providing contraceptive services in Kenya and Zimbabwe. Women aged 18-45 interested in newly initiating or switching contraception will choose from among all available contraceptive options, including Annovera. We aim to enroll 200 participants selecting Annovera and 200 participants selecting either contraceptive injectables or pills. We will compare method uptake, continuation, and satisfaction over one year. Participants will complete questionnaires administered by study staff during two in-person visits (a screening/enrollment visit, and an end of study visit after 52 weeks of method use or at discontinuation) and four phone appointments (at 4, 12, 24, and 36 weeks of use). We will evaluate used rings for discoloration and residual drug levels. The qualitative component involve in-depth interviews with women in the clinical study, their sexual partners, and their service providers, to further examine drivers of and barriers to interest in and use of contraceptive vaginal rings.

Discussion: This study will explore acceptability of contraceptive vaginal rings in 'real-world' contraceptive service settings in two African countries. Findings will be based on actual ring use and contextualized via comparison to two other commonly available methods. As vaginal rings are being considered for multiple reproductive health indications, this work can fill key knowledge gaps and empower decision-makers with information needed to inform future investments in reproductive health.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Gates Open Research
Gates Open Research Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
3.60
自引率
0.00%
发文量
90
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信